header logo image


Page 950«..1020..949950951952..960970..»

Study finds drinking may lower risk for diabetes – WTMJ-TV (press release) (registration) (blog)

August 28th, 2017 1:42 am

A recent study published by theEuropean Association for the Study of Diabetes has recently discovered that those who frequently consume alcohol have a reduced risk of developing diabetes.

The study, conducted byProfessor Janne Tolstrup and colleagues from the National Institute of Public Health of the University of Southern Denmark, examined the effects of drinking frequency on diabetes risk over the course of several years. Using data from the Danish Health Examination Survey, conducted between 2007 and 2008, over 70,000 participants were continually followed up with until 2012.

Danish citizens aged 18 and over completed the self-reporting questionnaire, which included questions regarding their lifestyle and health. Factors such as drinking patterns, the types of drinks consumed, age, sex, lifestyle habits, diet and even body mass index were all taken into consideration.

Anyone who had previously been diagnosed with diabetes, pregnant women or women who had recently given birth were excluded.

The data was then analyzed and researchers found that those with the lowest risk of developing diabetes were the survey participants who consumed moderate amounts of alcohol.

Men who consume 14 drinks per week were found to have a 43 percent lower risk of developing diabetes relative to men who dont consume any alcohol. Women who consume nine drinks per week had a 58 percent lower risk of developing diabetes compared to those who abstain from all alcoholic beverages.

When considering the frequency in which one consumes alcohol, the studys data revealed that those who drink 3-4 days a week had the lowest risk of diabetesa 27 percent lower risk in men and a 32 percent lower risk for womencompared to individuals who drink less than one alcoholic beverage per week.

And if youre wondering what type of drink gives you the best chance of fending off diabetes, the authors of the study note that they really didnt see much of a difference in those who drank wine, beer or spirits. Or perhaps even all three.

[h/t: Science Daily]

This story originally appeared on Simplemost. Checkout Simplemost for other great tips and ideas to make the most out of life.

View post:
Study finds drinking may lower risk for diabetes - WTMJ-TV (press release) (registration) (blog)

Read More...

GE engineer conquered diabetes with bicycling – Albany Times Union

August 28th, 2017 1:42 am

Photo: Lori Van Buren, Albany Times Union

GE engineer conquered diabetes with bicycling

GE engineer Bill Monaghan kept in great shape as champion high school bicyclist. But as a became happily married dad he became less active and chubby.

His wife Natalie worried about his high cholesterol and obesity-related sleep apnea. When he was diagnosed with Type 2 diabetes, he returned to his biking passion and won back his health.

"He lost all the weight and the diabetes, high cholesterol and sleep apnea were all gone," Natalie says proudly.

Now, Monaghan is coaching about 40 Capital Region bike ridersincluding many diabeticsfor the Juvenile Diabetes Research Foundation's September 14-17 fundraising rides. Those rides range in length from 30 to 100 miles. All of the upstate New York JDRF Ride to Cure Diabetes start in Saratoga.

Monaghan posts details of his Saturday coaching rides on the JDRF Northeast New York website for those who would like to train with him.

"The diabetics I'm coaching are vigilant and take very good care of each other," said Monaghan, a Charlton resident. "They'll suggest we stop if they sense someone should check his or her blood sugar."

Monaghan loves Italian designed bikes but his key preference is that the bike be made of titanium bike because the metal is so strong. (The newer lightweight carbon bikes concern him because carbon crumbles under impact far more easily). He was so devoted to biking that he owned a White Plains bike shop for eight years where he became expert at fitting bikes to riders.

He remains such an evangelist for biking's health benefits that he spends Saturday afternoons at Freemans Bridge Sports in Scotia fitting customers for helmets and bikes. A properly adjusted bike seat can make all the difference between viewing a bike ride as fun or just a chore that burns calories.

"The fact is, you're going to be safer and have a better time on a $200 bike that is perfectly fitted for you than an $8,000 bike that doesn't fit," he said. "You're better off getting fitted at a local bike shop where people love bikes and know what they're doing. At a big box sports store, you might find a kid who only knows football in the bike department. And he's there putting together bikes primarily to earn Ramen noodle money, not because he knows how to fit bikes to customers."

Natalie accompanied him on his bike journey back to good health. They rode a tandem bike along the coast of Maine's Acadia National Park for about 26 miles. Then they rode to the top of Cadillac Mountain, which Natalie describes as three miles of sharp switchbacks. She doesn't remember it as grueling.

"It was romantic, with fog drifting around the mountain," she exclaimed. "And it was invigorating with all the clean air so I hope other people trying to get in shape will try it."

The JDRF Saratoga has a fundraising goal of $2.1 million and $$1,465,4331 in donations have been pledged in the name of various bicyclists as of Thursday afternoon. There are several locations across America where fundraising rides will roll out in September. Maryland-based Ben Etheridgeof JDRF's Greater Chesapeake and Potomac Chapter is coming to New York to participate in the Saratoga ride. As of this week, he raised $74,961 in pledged donations, more than any other rider.

"I've been participating in these rides for years all over the country because I have two children with Type 1 diabetes," Etheridge said. "Doctors are very optimistic that they can overcome through nutrition and fitness. About 25 percent of the riders each year have Type 1 diabetes."

To learn more about the Saratoga ride visit the JDRF website;

http://www2.jdrf.org/site/TR/Ride/JDRFNationalRide?pg=entry&fr_id=6889

Excerpt from:
GE engineer conquered diabetes with bicycling - Albany Times Union

Read More...

A New Way to Fight Heart Disease May Also Tackle Cancer – NBCNews.com

August 28th, 2017 1:41 am

Researchers say theyve proven a long-held theory about heart disease: that lowering inflammation may be nearly as important as cutting cholesterol levels.

They showed that using a targeted drug to reduce inflammation cut the risk of heart attacks, strokes and other events in patients who had already suffered one heart attack independent of any other treatment they got.

A bonus side-effect the treatment also appeared to have reduced rates of lung cancer diagnosis and death.

The studies, being presented at a meeting in Barcelona this weekend, are just a first step and do not yet open a door to a new way of treating heart patients.

And they dont necessarily apply to everybody. But Dr. Paul Ridker of Brigham and Womens Hospital and Harvard Medical School, who led the research team, thinks the findings will lead to ways to help people most at risk of dying of heart disease and stroke.

This plays beautifully into the whole idea of personalized medicine and trying to get the right drug to the right patient, Ridker said.

Novartis, which makes the drug, said it would ask the Food and Drug Administration for permission to market the drug as a way to prevent heart attacks and would start further tests on its effect in lung cancer.

Ridkers team tested 10,000 patients who had suffered one heart attack already and thus were at very high risk of having a second one. The patients all had high levels of high sensitivity C-reactive protein or CRP, a measure of inflammation in the body.

Related: FDA Approves Pricey New Cholesterol Drug

They were already taking a basket of medications for their heart disease, from cholesterol-lowering statins to blood pressure drugs.

On top of that, the team added a drug called canakinumab, a monoclonal antibody or magic bullet agent that targets a specific cause of inflammation called interleukin 1 beta.

Volunteers got either a placebo, or injections every three months of low, medium or high doses of canakinumab.

After three to four years, people who got the highest dose of the drug were the least likely to have had another heart attack, stroke or to have died of heart disease.

Those who got the two highest doses of canakinumab had a 15 percent lower chance of having a heart attack, stroke or other major cardiovascular event, the team found. Patients were also less likely to need a heart bypass or angioplasty to clear out clogged arteries.

For the first time, weve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk, Ridker said.

Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic, who was not involved in the study, said the results were impressive. It shows us that people with high levels of inflammation - if you target the inflammation - you can reduce the risk of heart attack stroke and death, Nissen said.

Related: Here's How Stress Might Cause Heart Attacks, Strokes

The results are being presented at the European Society of Cardiology meeting in Barcelona, and also published in the New England Journal of Medicine and the Lancet medical journal.

Its been long known that both inflammation and cholesterol buildup are involved in heart and artery disease.

Inflammation is part of the bodys immune process, and the patients in the trial were more likely to suffer serious infections, including pneumonia. The same thing happens to people taking immune-suppressing drugs to fight rheumatoid arthritis.

Physicians would have to be cautious, Ridker said.

But the researchers found some other side-effects. People taking the higher doses of canakinumab had lower rates of cancer, especially lung cancer, as well as lower rates of arthritis and gout.

This makes sense to Ridker.

If you smoke a pack of cigarettes, you chronically inflame the lung. If you are a long-haul truck driver breathing in diesel, you are chronically inflaming the lung, he said. Inflammation can drive cancer as well as heart disease, he said.

These are fascinating, human findings that open a potential new class of therapies for cancer, said Dr. Laurie Glimcher, president and CEO of the Dana-Farber Cancer Institute.

Ridker does not believe the drug prevents cancer. He thinks inflammation may fuel the growth of some tumors.

The tumors were obviously already there. They were just small and undiagnosed, he said.

Related: Heart Attacks, Strokes, Fell After Trans-Fat Ban

The findings will not immediately mean new treatments for heart disease patients. For one thing, like any medical finding, theyll have to be replicated by other researchers. Ridkers testing another drug, methotrexate, thats also used to treat rheumatoid arthritis.

While canakinumab has already been approved by the FDA, it is a so-called orphan drug used to treat a very rare genetic condition. Sold under the brand name Ilaris, it costs about $200,000 a year.

We look forward to submitting the ... data to regulatory authorities for approval in cardiovascular and initiating additional phase III studies in lung cancer," said Vas Narasimhan, who heads drug development for Novartis.

Ridker says he is pressing Novartis to try something different, perhaps offering the first dose of the drug free. People whose CRP levels fell more after their first dose also tended to be those who had lower rates of heart attacks and strokes years later.

It might be worth taking one dose and see if you respond. If you dont, well, there is no reason to be on the drug, he said.

This is the way to really focus these treatments on the patients on whom it really works. I think thats just good medicine.

In the end, Ridker believes, some extreme heart disease patients will be helped more by the newest cholesterol-lowering drugs, called PCSK9 inhibitors, while others may be better helped by targeted anti-inflammatory drugs.

Half of heart attacks occur in people who do not have high cholesterol, he said. For the first time, weve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk.

Nissen agrees.

I think its a game changer. The only good therapies weve had so far were statins. But now it seems like we have something new in the future, he said.

It opens up pathways to new research and new treatments in the future. There are many other anti-inflammatory activities going on in our body, not just the one thats tackled by canakinumab. There will be so many more studies now to see if other therapies that tackle other pathways will also reduce the risk.

And the findings may offer some common-sense advice to everyone about lowering inflammation, Ridker said.

Theres a lot you can do about it right now, he said.

If your high sensitivity C-reactive protein is elevated, you are a high-risk patient. This is overwhelming evidence that you should go to the gym, throw out the cigarettes, eat a healthier diet, he said.

Because all three of those well-known interventions lower your inflammatory burden.

Continue reading here:
A New Way to Fight Heart Disease May Also Tackle Cancer - NBCNews.com

Read More...

5 ways 3D printing could totally change medicine – Futurity: Research News

August 28th, 2017 1:41 am

A new study aims to alert medical professionals to the potential of 3D printings future use in the field.

3D printing technology is going to transform medicine, whether it is patient-specific surgical models, custom-made prosthetics, personalized on-demand medicines, or even 3D printed human tissue, says Jason Chuen, Director of Vascular Surgery at Austin Health and a Clinical Fellow at the University of Melbourne.

Before inserting and expanding a pen-sized stent into someones aorta, the hose-like artery that carries our blood away from the heart, Chuen, a surgeon, likes to practice on the patient first. Not for real of course, but in plastic.

He has a 3D printer in his office and brightly colored plastic aortas line his window sill at the Austin Hospital in Melbourne. They are all modeled from real patients and printed out from CT scans, ultrasounds, and x-rays.

By using the model I can more easily assess that the stent is the right size and bends in exactly the right way when I deploy it, says Chuen.

At the moment 3D printing is at the cutting edge of medical research, but in the future the technology will be taken for granted by all of us in healthcare, he says.

At its core 3D printing is the use of computer guidance technology to create 3D objects from digital plans by applying layers of material, such as heated plastic, or powders in the case of metals and ceramics. It is being used to print out anything from toys and food, to warships producing on-demand spare parts and even drones. Medicine is just another frontier.

The new paper, coauthored by Chuen and Jasamine Coles-Black, from the Austin Hospital in Melbourne, appears in the Medical Journal of Australia.

Here are the top five areas in which 3D printing is set to change medicine, according to the Chuen and Coles-Black:

It sounds like something out of Frankenstein, but could we eventually 3D print human organs? Not exactly, says Chuen. But hes convinced that in the future we will be able to 3D print human tissue structures that can perform the basic functions of an organ, replacing the need for some transplants.

Scientists are already using 3D printing to build organoids that mimic organs at a tiny scale and can be used for research. They are built using stem cells that can be stimulated to grow into the functional unit of a particular organ, such as a liver or kidney. The challenge he says is to scale up organoids into a structure that could boost a failing organ inside a patient.

we are moving towards a world where if you can imagine it, you will be able to print it

Such bioprinting involves using a computer-guided pipette that takes up cell cultures suspended in nutrient rich solution and prints them out in layers suspended in a gel. Without the gel the cells would simply become a watery mess.

The problem, says Chuen, is that once inside the gel, cells can die in a matter of minutes. This isnt a problem for small structures like organoids that can be built quickly and then transferred back into a nutrient solution. But it is a problem when attempting to make something larger like an organ because the initial layers of cells will die before the organ is completed.

Unless there is some breakthrough that enables us to keep the cells alive while we print them, then I think printing a full human organ will remain impossible. But where there is potential is in working out how to reliably build organoids or components that we could then bind together to make them function like an organ, says Chuen.

People suffering from a range of ailments, such as the elderly, are often dependent on taking multiple pills throughout the day. But imagine if one pill could replace the ten pills your doctor has prescribed?

According to Chuen, 3D printing is on the way to making this possible, opening up a whole new world of customized medicines.

Rather than simply embedding a single drug in a pill that is designed to dissolve and release the drug at a set time, the precision of 3D printing means pills can be designed to house several drugs, all with different release times. A 3D printed polypill that contains three different drugs has already been developed for patients with diabetes and hypertension.

It maybe that in the future instead of a prescription your doctor will be giving you a digital file of printing instructions.

Studies of surgeons using 3D printed models to rehearse procedures have shown that operations can be completed faster and with less trauma for patients. The potential cost savings alone are considerable. As Chuenpoints out, running an operating theatre can cost AUD$2,000 an hour. That is over AUD$30 a minute.

Chuen and Coles-Black themselves have begun printing out copies of patient kidneys to help surgeons at the Austin in planning the removal of kidney tumors. Such hard plastic models can be made more realistic by printing them in more expensive flexible material such as thermoplastic polyurethane. The material cost of the hard plastic aortas in Chuens office is about AUD$15 (less than $12 in the United States), whereas if printed in soft plastic the cost can rise to AUD$50 (less than $40 USD).

The real cost in 3D printing biological models is not just materials or printers, but also the software used to translate the scans into files for the printer. The 3D segmentation software Chuen uses costs about AUD$20,000 a year (under $16,000 USD).

As soon as 3D printing began to take off people were quick to see the opportunity for creating amateur prosthetics for their petsfrom puppies to geese, and even tortoises. Unlike for humans, there was no mass-supply chain of prosthetics for pets. But mass-supplied prosthetics are likely to be a thing of the past as 3D printing is increasingly used to manufacture prosthetics that are exactly tailored to a patients needs.

For example, with hip replacements, surgeons have to cut and ream a patients bone to fit the prosthetic, but in the future, it will be normal to 3D print a prosthetic to fit a patient, says Chuen.

Just as 3D printing is allowing customized production of medicines and devices, the production itself is likely to become localized. The warehouses that are full of packaged medicines and prosthetics will in the future likely be replaced by digital files of designs that hospitals and pharmacies will be able to download and print on demand using stored raw materials, says Chuen.

Such distributed manufacturing, he says, could make medicines and devices more equitably available across the world so long as a local hospital for instance has the printing technology in place and access to raw materials.

However, Chuen warns distributed production will present new risks for ensuring the quality control of end products. It will need a fundamental shift in responsibility from the supplier to wherever the medicines or devices are manufactured. That represents a huge shift and we have to work out how it could work. But if we get the regulation right then it will transform access to medical products.

But for Chuen, the immediate overall challenge in medical 3D printing is ensuring that medical professionals themselves are up to speed with the technology because it is their clinical experience that will be needed to drive its successful application.

It is a revolutionary technology that will make medical care better and faster, and more personalized. But what we need is for more medical professionals to start exploring and experimenting with what this new technology can do, because many things that we thought of as impossible are now becoming possible.

I think we are moving towards a world where if you can imagine it, you will be able to print itso we need to start imagining, Chuen says.

Source: University of Melbourne

Original Study DOI: 10.5694/mja16.01073

Visit link:
5 ways 3D printing could totally change medicine - Futurity: Research News

Read More...

WISH researcher contributes to book on oral cancer – Gulf Times

August 28th, 2017 1:41 am

Dr Walid Qoronfleh, director of research and policy at the World Innovation Summit for Health (WISH), has co-authored a chapter of a book that takes an in-depth look at cancers of the mouth, known as human oral cancer.The book, Development of Oral Cancer: Risk Factors and Prevention Strategies, identifies different aspects of human oral cancer as a step toward the alleviation and prevention of the disease.Oral cancer is one of the most common non-communicable diseases worldwide with an estimated 300,000 new cases and 145,000 deaths in 2012.Dr Qoronflehs contribution, a chapter entitled Novel Developments in the Molecular Genetic Basis of Oral Squamous Cell Carcinoma, is co-authored with Dr Nader al-Dewik from the Qatar Medical Genetics Centre, part of Hamad Medical Corporation.The chapter examines the most common molecular genetic alterations of cancer cells and the role of these cells in the development of oral cancer, with a view to help develop targeted therapeutic approaches to the disease.Oral health and tobacco cessation are key health areas for the Ministry of Public Health, as per the Qatar Public Health Strategy 2017-2022.Dr Qoronfleh said: Early stage detection not only improves prognosis but also increases the survival rate and enhances a patients quality of life. Advances in the understanding of the molecular basis of oral cancer should help in the identification of new biomarkers and open new horizons for therapy, especially targeted therapy, which is likely to be more successful in the long run.Another way to combat oral cancer is education. Public awareness programmes are necessary tools to fight oral cancer at all levels in terms of diagnosis, risk management, and treatment monitoring.The greatest challenge related to oral cancer is that the disease is often not detected early enough for successful treatment. The World Health Organisation has reported that oral cancer malignancies and mortality are increasing, with an alarming rise in incidence among young people in the Arab world due to various tobacco habits.Development of Oral Cancer: Risk Factors and Prevention Strategies is published by Springer International Publishing and is edited by Ala-Eddin al-Moustafa, a professor at the College of Medicine at Qatar University and adjunct professor of the oncology department of McGill University, Canada.

See more here:
WISH researcher contributes to book on oral cancer - Gulf Times

Read More...

Genetic and epigenetic epidemiology of chronic widespread pain – Dove Medical Press

August 28th, 2017 1:41 am

Jasmine I Kerr,1 Andrea Burri,13

1Department of Psychology, University of Zurich, Zurich, Switzerland; 2Department of Physiotherapy, Health and Rehabilitation Research Institute, Auckland University of Technology, 3Waitemata Pain Service, Department of Anesthesia and Perioperative Medicine, North Shore Hospital, Auckland, New Zealand

Abstract: The etiology underlying chronic widespread pain (CWP) remains largely unknown. An integrative biopsychosocial model seems to yield the most promising explanations for the pathogenesis of the condition, with genetic factors also contributing to disease development and maintenance. Here, we conducted a search of studies investigating the genetic and epigenetic epidemiology of CWP through electronic databases including Web of Science, Medline, PubMed, EMBASE, and Google Scholar. Combinations of keywords including CWP, chronic pain, musculoskeletal pain, genetics, epigenetics, gene, twins, single-nucleotide polymorphism, genotype, and alleles were used. In the end, a total of 15 publications were considered relevant to be included in this review: eight were twin studies on CWP, six were molecular genetic studies on CWP, and one was an epigenetic study on CWP. The findings suggest genetic and unique environmental factors to contribute to CWP. Various candidates such as serotonin-related pathway genes were found to be associated with CWP and somatoform symptoms. However, studies show some limitations and need replication. The presented results for CWP could serve as a template for genetic studies on other chronic pain conditions. Ultimately, a more in-depth understanding of disease mechanisms will help with the development of more effective treatment, inform nosology, and reduce the stigma still lingering on this diagnosis.

Keywords: chronic widespread pain, CWP, epigenetics, genetics, twin studies, environment, aetiology

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the original post here:
Genetic and epigenetic epidemiology of chronic widespread pain - Dove Medical Press

Read More...

First TEDx event held in Duhok ‘gives people an opportunity to think’ – Rudaw

August 28th, 2017 1:41 am

DUHOK, Kurdistan Region It took approximately five months and 75 volunteers of all ages to finalize everything needed to host the first ever TEDx event in Duhok, a mountainous city and a tourist spot located in the northern part of the Kurdistan Region.

For the organizers, it is about giving motivated speakers an opportunity to share their life journey, like Wahid Chicho who was born a dwarf and is married with two children but was once told he will never have a family of his own.

A group of entrepreneurs, inventors, IT experts, medical professionals and other talented motivational speakers came together on Saturday to share their experiences and knowledge with locals and foreign nationals alike in the event.

Salih said the organizers first started the process to host the event in Duhok almost a year ago and after licensing and sponsorship were approved, they were able to put it together.

A total of 11 speakers were each allowed between 15-18 minutes to share their personal stories of life experiences and education to help inspire hundreds of people who joined the event become motivated to create a better future for themselves.

The speakers were mostly from Duhok, but also came from other parts of Iraq and the Kurdistan region such as Sulaimani, Zakho, Bashiqa, Mosul and even as far as Los Angeles, California in the United States.

Here we are trying to look for, promote and bring ideas on stage where they [the speakers] can express their feelings, their ideas freely, Executive Producer, Hussam Mohammed said. I think there are not many places to do this, so TEDx Duhok gives us the platform, the frame where we can bring and motivate young people to bring their ideas.

Mohammed believes it is important for young, creative thinkers to deliver their ideas to others which will encourage and motivate others to move forward in their lives. This was one of the main reasons to bring TEDx to Duhok, he said.

Plus, we think that Duhok people deserve the best and weve tried to bring the best here to Duhok, Muhammad added.

One speaker, Wahid Chicho, age 31 from Duhok, spoke of the struggles and difficulties he had being born as a dwarf. Regardless of the discrimination he faced growing up; he completed his studies and went on to establish the Kurdistan Dwarf Association Duhok Branch.

Wahid Chicho delivers his speech at Duhok's first TEDx event on August 26, 2017. Photo by author.

He had been told that he would never be able to have a family, but today he is married and has two children. Chicho also went on to establish the Kurdistan Paralympic Committee/Duhok Representative Office and the Duhok Disabled Network.

Hezha Khan, age 26, from Sulaimani was another speaker who became Founder/CEO of APC for Youth Empowerment that encourages economically disadvantaged Kurdish youth to become change makers in their local communities. She is also a Country Representative who travels the world encouraging peace in the Middle East and Africa through speeches and workshops.

Khan believes that the government as well as todays youth play a crucial role in bringing about social change and women equality in their communities, especially with the upcoming Kurdish referendum for independence on September 25. Khan encourages people to challenge themselves and to follow their dreams.

Levi Clancy, age 26 from Los Angeles is currently a software developer and freelance journalist living in Erbil. Clancy, who began university when he was 13-years-old and graduated with a major in Microbiology, Immunology and Molecular Genetics and a minor in Mesopotamian History was drawn to the Kurdistan region after visiting as a tourist in 2010.

Clancy spoke about the Kurdistan region as being a safe, tolerant and diverse state in a region torn by war and instability.

He also highlighted the acceptance of the diverse ethnic and religious groups living here.

Clancy described Kurdistan as, It is its own country but for now and against all odds, a country inside of another country.

Because even though the map says Iraq, but the reason that I as an American, as a Jew, with no security or guards or anything, can call this home is because I am in Kurdistan, he added.

Clancy said that as an American he cant say that Kurds should vote yes or no in the upcoming referendum. However, he did say that Kurdistan is a sort of example for the world in the issues of the future.

Video:Levi Clancy, age 26 from Los Angeles is currently a software developer and freelance journalist living in Erbil. He shared his thoughts on Kurdistan and its bid to hold independence referendum.

The event also brought together a diverse group of volunteers of all ages who worked for several months in the planning and physical preparation of hosting a world famous event.

Aryan, age 21, a medical student at the University of Duhok volunteered by helping with photography. She said the group worked well together to bring a meaningful event to their community.

This was the first great step if we are thinking of becoming a great country, Aryan said. TEDx Duhok was the first step towards changing our society. I saw people in the audience getting affected by such great, bright ideas that the speakers were talking about and especially when they introduced Kurdistan to other nations.

When Executive Producer Mohammed was asked if they would bring TEDx back to Duhok again, he responded, This is the end of the beginning. The journey has to continue and well try to do our best to make better results."

I urge the communities around the world to bring TEDx to their communities because communities have ideas and are creative and can do great things, but they need a platform. TEDx can be their platform.

See the original post:
First TEDx event held in Duhok 'gives people an opportunity to think' - Rudaw

Read More...

Introduction to genetics – Wikipedia

August 28th, 2017 1:40 am

This article is a non-technical introduction to the subject. For the main encyclopedia article, see Genetics.

A long molecule that looks like a twisted ladder. It is made of four types of simple units and the sequence of these units carries information, just as the sequence of letters carries information on a page.

They form the rungs of the DNA ladder and are the repeating units in DNA. There are four types of nucleotides (A, T, G and C) and it is the sequence of these nucleotides that carries information.

A package for carrying DNA in the cells. They contain a single long piece of DNA that is wound up and bunched together into a compact structure. Different species of plants and animals have different numbers and sizes of chromosomes.

A segment of DNA. Genes are like sentences made of the "letters" of the nucleotide alphabet, between them genes direct the physical development and behavior of an organism. Genes are like a recipe or instruction book, providing information that an organism needs so it can build or do something - like making an eye or a leg, or repairing a wound.

The different forms of a given gene that an organism may possess. For example, in humans, one allele of the eye-color gene produces green eyes and another allele of the eye-color gene produces brown eyes.

The complete set of genes in a particular organism.

When people change an organism by adding new genes, or deleting genes from its genome.

An event that changes the sequence of the DNA in a gene.

Genetics is the study of geneswhat they are, what they do, and how they work. Genes inside the nucleus of a cell are strung together in such a way that the sequence carries information: that information determines how living organisms inherit various features (phenotypic traits). For example, offspring produced by sexual reproduction usually look similar to each of their parents because they have inherited some of each of their parents' genes. Genetics identifies which features are inherited, and explains how these features pass from generation to generation. In addition to inheritance, genetics studies how genes are turned on and off to control what substances are made in a cellgene expression; and how a cell dividesmitosis or meiosis.

Some phenotypic traits can be seen, such as eye color while others can only be detected, such as blood type or intelligence. Traits determined by genes can be modified by the animal's surroundings (environment): for example, the general design of a tiger's stripes is inherited, but the specific stripe pattern is determined by the tiger's surroundings. Another example is a person's height: it is determined by both genetics and nutrition.

Chromosomes are tiny packages which contain one DNA molecule and its associated proteins. Humans have 46 chromosomes (23 pairs). This number varies between speciesfor example, many primates have 24 pairs. Meiosis creates special cells, sperm in males and eggs in females, which only have 23 chromosomes. These two cells merge into one during the fertilization stage of sexual reproduction, creating a zygote. In a zygote, a nucleic acid double helix divides, with each single helix occupying one of the daughter cells, resulting in half the normal number of genes. By the time the zygote divides again, genetic recombination has created a new embryo with 23 pairs of chromosomes, half from each parent. Mating and resultant mate choice result in sexual selection. In normal cell division (mitosis) is possible when the double helix separates, and a complement of each separated half is made, resulting in two identical double helices in one cell, with each occupying one of the two new daughter cells created when the cell divides.

Chromosomes all contain DNA made up of four nucleotides, abbreviated C (cytosine), G (guanine), A (adenine), or T (thymine), which line up in a particular sequence and make a long string. There are two strings of nucleotides coiled around one another in each chromosome: a double helix. C on one string is always opposite from G on the other string; A is always opposite T. There are about 3.2 billion nucleotide pairs on all the human chromosomes: this is the human genome. The order of the nucleotides carries genetic information, whose rules are defined by the genetic code, similar to how the order of letters on a page of text carries information. Three nucleotides in a rowa tripletcarry one unit of information: a codon.

The genetic code not only controls inheritance: it also controls gene expression, which occurs when a portion of the double helix is uncoiled, exposing a series of the nucleotides, which are within the interior of the DNA. This series of exposed triplets (codons) carries the information to allow machinery in the cell to "read" the codons on the exposed DNA, which results in the making of RNA molecules. RNA in turn makes either amino acids or microRNA, which are responsible for all of the structure and function of a living organism; i.e. they determine all the features of the cell and thus the entire individual. Closing the uncoiled segment turns off the gene.

Heritability means the information in a given gene is not always exactly the same in every individual in that species, so the same gene in different individuals does not give exactly the same instructions. Each unique form of a single gene is called an allele; different forms are collectively called polymorphisms. As an example, one allele for the gene for hair color and skin cell pigmentation could instruct the body to produce black pigment, producing black hair and pigmented skin; while a different allele of the same gene in a different individual could give garbled instructions that would result in a failure to produce any pigment, giving white hair and no pigmented skin: albinism. Mutations are random changes in genes creating new alleles, which in turn produce new traits, which could help, harm, or have no new effect on the individual's likelihood of survival; thus, mutations are the basis for evolution.

Contents

Genes are pieces of DNA that contain information for synthesis of ribonucleic acids (RNAs) or polypeptides. Genes are inherited as units, with two parents dividing out copies of their genes to their offspring. This process can be compared with mixing two hands of cards, shuffling them, and then dealing them out again. Humans have two copies of each of their genes, and make copies that are found in eggs or spermbut they only include one copy of each type of gene. An egg and sperm join to form a complete set of genes. The eventually resulting offspring has the same number of genes as their parents, but for any gene one of their two copies comes from their father, and one from their mother.[1]

The effects of this mixing depend on the types (the alleles) of the gene. If the father has two copies of an allele for red hair, and the mother has two copies for brown hair, all their children get the two alleles that give different instructions, one for red hair and one for brown. The hair color of these children depends on how these alleles work together. If one allele dominates the instructions from another, it is called the dominant allele, and the allele that is overridden is called the recessive allele. In the case of a daughter with alleles for both red and brown hair, brown is dominant and she ends up with brown hair.[2]

Although the red color allele is still there in this brown-haired girl, it doesn't show. This is a difference between what you see on the surface (the traits of an organism, called its phenotype) and the genes within the organism (its genotype). In this example you can call the allele for brown "B" and the allele for red "b". (It is normal to write dominant alleles with capital letters and recessive ones with lower-case letters.) The brown hair daughter has the "brown hair phenotype" but her genotype is Bb, with one copy of the B allele, and one of the b allele.

Now imagine that this woman grows up and has children with a brown-haired man who also has a Bb genotype. Her eggs will be a mixture of two types, one sort containing the B allele, and one sort the b allele. Similarly, her partner will produce a mix of two types of sperm containing one or the other of these two alleles. When the transmitted genes are joined up in their offspring, these children have a chance of getting either brown or red hair, since they could get a genotype of BB = brown hair, Bb = brown hair or bb = red hair. In this generation, there is therefore a chance of the recessive allele showing itself in the phenotype of the childrensome of them may have red hair like their grandfather.[2]

Many traits are inherited in a more complicated way than the example above. This can happen when there are several genes involved, each contributing a small part to the end result. Tall people tend to have tall children because their children get a package of many alleles that each contribute a bit to how much they grow. However, there are not clear groups of "short people" and "tall people", like there are groups of people with brown or red hair. This is because of the large number of genes involved; this makes the trait very variable and people are of many different heights.[3] Despite a common misconception, the green/blue eye traits are also inherited in this complex inheritance model.[4] Inheritance can also be complicated when the trait depends on interaction between genetics and environment. For example, malnutrition does not change traits like eye color, but can stunt growth.[5]

Some diseases are hereditary and run in families; others, such as infectious diseases, are caused by the environment. Other diseases come from a combination of genes and the environment.[6]Genetic disorders are diseases that are caused by a single allele of a gene and are inherited in families. These include Huntington's disease, Cystic fibrosis or Duchenne muscular dystrophy. Cystic fibrosis, for example, is caused by mutations in a single gene called CFTR and is inherited as a recessive trait.[7]

Other diseases are influenced by genetics, but the genes a person gets from their parents only change their risk of getting a disease. Most of these diseases are inherited in a complex way, with either multiple genes involved, or coming from both genes and the environment. As an example, the risk of breast cancer is 50 times higher in the families most at risk, compared to the families least at risk. This variation is probably due to a large number of alleles, each changing the risk a little bit.[8] Several of the genes have been identified, such as BRCA1 and BRCA2, but not all of them. However, although some of the risk is genetic, the risk of this cancer is also increased by being overweight, drinking a lot of alcohol and not exercising.[9] A woman's risk of breast cancer therefore comes from a large number of alleles interacting with her environment, so it is very hard to predict.

The function of genes is to provide the information needed to make molecules called proteins in cells.[1] Cells are the smallest independent parts of organisms: the human body contains about 100 trillion cells, while very small organisms like bacteria are just one single cell. A cell is like a miniature and very complex factory that can make all the parts needed to produce a copy of itself, which happens when cells divide. There is a simple division of labor in cellsgenes give instructions and proteins carry out these instructions, tasks like building a new copy of a cell, or repairing damage.[10] Each type of protein is a specialist that only does one job, so if a cell needs to do something new, it must make a new protein to do this job. Similarly, if a cell needs to do something faster or slower than before, it makes more or less of the protein responsible. Genes tell cells what to do by telling them which proteins to make and in what amounts.

Proteins are made of a chain of 20 different types of amino acid molecules. This chain folds up into a compact shape, rather like an untidy ball of string. The shape of the protein is determined by the sequence of amino acids along its chain and it is this shape that, in turn, determines what the protein does.[10] For example, some proteins have parts of their surface that perfectly match the shape of another molecule, allowing the protein to bind to this molecule very tightly. Other proteins are enzymes, which are like tiny machines that alter other molecules.[11]

The information in DNA is held in the sequence of the repeating units along the DNA chain.[12] These units are four types of nucleotides (A,T,G and C) and the sequence of nucleotides stores information in an alphabet called the genetic code. When a gene is read by a cell the DNA sequence is copied into a very similar molecule called RNA (this process is called transcription). Transcription is controlled by other DNA sequences (such as promoters), which show a cell where genes are, and control how often they are copied. The RNA copy made from a gene is then fed through a structure called a ribosome, which translates the sequence of nucleotides in the RNA into the correct sequence of amino acids and joins these amino acids together to make a complete protein chain. The new protein then folds up into its active form. The process of moving information from the language of RNA into the language of amino acids is called translation.[13]

If the sequence of the nucleotides in a gene changes, the sequence of the amino acids in the protein it produces may also changeif part of a gene is deleted, the protein produced is shorter and may not work any more.[10] This is the reason why different alleles of a gene can have different effects in an organism. As an example, hair color depends on how much of a dark substance called melanin is put into the hair as it grows. If a person has a normal set of the genes involved in making melanin, they make all the proteins needed and they grow dark hair. However, if the alleles for a particular protein have different sequences and produce proteins that can't do their jobs, no melanin is produced and the person has white skin and hair (albinism).[14]

Genes are copied each time a cell divides into two new cells. The process that copies DNA is called DNA replication.[12] It is through a similar process that a child inherits genes from its parents, when a copy from the mother is mixed with a copy from the father.

DNA can be copied very easily and accurately because each piece of DNA can direct the creation of a new copy of its information. This is because DNA is made of two strands that pair together like the two sides of a zipper. The nucleotides are in the center, like the teeth in the zipper, and pair up to hold the two strands together. Importantly, the four different sorts of nucleotides are different shapes, so for the strands to close up properly, an A nucleotide must go opposite a T nucleotide, and a G opposite a C. This exact pairing is called base pairing.[12]

When DNA is copied, the two strands of the old DNA are pulled apart by enzymes; then they pair up with new nucleotides and then close. This produces two new pieces of DNA, each containing one strand from the old DNA and one newly made strand. This process is not predictably perfect as proteins attach to a nucleotide while they are building and cause a change in the sequence of that gene. These changes in DNA sequence are called mutations.[15] Mutations produce new alleles of genes. Sometimes these changes stop the functioning of that gene or make it serve another advantageous function, such as the melanin genes discussed above. These mutations and their effects on the traits of organisms are one of the causes of evolution.[16]

A population of organisms evolves when an inherited trait becomes more common or less common over time.[16] For instance, all the mice living on an island would be a single population of mice: some with white fur, some gray. If over generations, white mice became more frequent and gray mice less frequent, then the color of the fur in this population of mice would be evolving. In terms of genetics, this is called an increase in allele frequency.

Alleles become more or less common either by chance in a process called genetic drift, or by natural selection.[17] In natural selection, if an allele makes it more likely for an organism to survive and reproduce, then over time this allele becomes more common. But if an allele is harmful, natural selection makes it less common. In the above example, if the island were getting colder each year and snow became present for much of the time, then the allele for white fur would favor survival, since predators would be less likely to see them against the snow, and more likely to see the gray mice. Over time white mice would become more and more frequent, while gray mice less and less.

Mutations create new alleles. These alleles have new DNA sequences and can produce proteins with new properties.[18] So if an island was populated entirely by black mice, mutations could happen creating alleles for white fur. The combination of mutations creating new alleles at random, and natural selection picking out those that are useful, causes adaptation. This is when organisms change in ways that help them to survive and reproduce. Many such changes, studied in evolutionary developmental biology, affect the way the embryo develops into an adult body.

Since traits come from the genes in a cell, putting a new piece of DNA into a cell can produce a new trait. This is how genetic engineering works. For example, rice can be given genes from a maize and a soil bacteria so the rice produces beta-carotene, which the body converts to Vitamin A.[19] This can help children suffering from Vitamin A deficiency. Another gene being put into some crops comes from the bacterium Bacillus thuringiensis; the gene makes a protein that is an insecticide. The insecticide kills insects that eat the plants, but is harmless to people.[20] In these plants, the new genes are put into the plant before it is grown, so the genes are in every part of the plant, including its seeds.[21] The plant's offspring inherit the new genes, which has led to concern about the spread of new traits into wild plants.[22]

The kind of technology used in genetic engineering is also being developed to treat people with genetic disorders in an experimental medical technique called gene therapy.[23] However, here the new gene is put in after the person has grown up and become ill, so any new gene is not inherited by their children. Gene therapy works by trying to replace the allele that causes the disease with an allele that works properly.

See the rest here:
Introduction to genetics - Wikipedia

Read More...

UNL partners with University of Montana to study plant adaptation genetics – Daily Nebraskan

August 28th, 2017 1:40 am

A new research partnership at the University of Nebraska-Lincoln will focus on how genetic adaptations in plants and animals have helped animals evolve and withstand environmental challenges.

A four-year, $4 million National Science Foundation study will partner UNL with the University of Montana.

Species of both plants and animals can be present in vastly different local conditions, and learn to adapt to their conditions, said Jay Storz, a UNL Susan J. Rosowski professor of biological sciences.

Were looking at ways to figure out the causal connections between information encoded in the genome and the traits involved in those adaptations, he said.

The team will analyze genomes of animals and plants that have shown they can adapt to different conditions. Researchers will compare the genomes to those of the same species and of species that do not adapt to other climates to establish a link between genetic changes and environment-specific traits.

It might help you narrow down your search of the whole genome to a more targeted set of candidate genes, said Kristi Montooth, associate professor of biological sciences at UNL. If you can kind of back track from the physiology and try to match physiological changes to changes in gene expression, then you may be able to better localize in the genome what changes might be responsible for that [trait].

Colin Meiklejohn, an assistant professor of biological sciences at UNL, said this will give them the potential to help populations that are going extinct and give them the ability to survive. If there is a closely related species, scientists could breed the two species together and save a population while also potentially giving the species the ability to adapt better than before.

A yearly meeting will give researchers a chance to discuss their progress and debate questions they find during their research. Each institution will be hiring four postdoctoral researchers and full-time research assistants to help with the project. The positions will be funded by the project.

Montooth said a majority of the money from the project fund will be used toward training the next generation of evolutionary geneticists.

news@dailynebraskan.com

See more here:
UNL partners with University of Montana to study plant adaptation genetics - Daily Nebraskan

Read More...

Warnings over shock dementia revelations from ancestry DNA tests – The Guardian

August 28th, 2017 1:40 am

People who use genetic tests to trace their ancestry only to discover that they are at risk of succumbing to an incurable illness are being left to suffer serious psychological problems. Dementia researchers say the problem is particularly acute for those found to be at risk of Alzheimers disease, which has no cure or effective treatment. Yet these people are stumbling upon their status inadvertently after trying to find their Viking, Asian or ancient Greek roots.

These tests have the potential to cause great distress, said Anna Middleton, head of society and ethics research at the Wellcome Genome Campus in Cambridge. Companies should make counselling available, before and after people take tests. The issue is raised in a paper by Middleton and others in the journal Future Medicine.

A similar warning was sounded by Louise Walker, research officer at the Alzheimers Society. Everyone has a right to know about their risk if they want to, but these companies have a moral responsibility to make sure people understand the meaning and consequences of this information. Anyone considering getting genetic test results should do so with their eyes open.

Alzheimers is linked to the build-up in the brain of clumps of a protein called amyloid. This triggers severe memory loss, confusion and disorientation. One gene, known as ApoE, affects this process and exists in three variants: E2, E3 and E4. Those possessing the last of these face an increased chance of getting the disease in late life.

About 3% of the population has two copies of the E4 variant one inherited from each parent, Professor John Hardy, of University College London, said. They have about an 80% chance of getting Alzheimers by the age of 80. The average person has a 10% risk.

The gene test company has made its profit and walks away. They should be made to pay for their customers' counselling

The link with ApoE was made in 1996 and Hardy recalled the reaction in his laboratory. We went around testing ourselves to see which variant we possessed. I found I have two low-risk E3 versions on my genome. But if I had found two E4 versions? By now, having reached my 60s, I would be facing the prospect that I had a serious chance of getting Alzheimers disease in 10 years. I would be pretty fed up.

The ability to find a persons ApoE status has become even easier as a result of the development of genetic tests that provide information about a persons ancestry, health risks and general traits. Dozens of companies offer such services and adverts portray happy individuals learning about their roots 43% African or 51% Middle Eastern often to the sound of Julie Andrews singing Getting to Know You or a similarly happy-sounding track. All you have to do is provide a sample of spittle.

The resulting information about predilections to disease is not stressed but it is given. Kelly Boughtflower, from London, took a gene test with the company 23andMe because she wanted to prove her mothers family came from Spain. The results provided no evidence of her Iberian roots but revealed she carried one E4 version of the ApoE gene, which increases her chances of getting Alzheimers, though not as drastically as a double dose.

I didnt think about it at the time, said Boughtflower. Then, when I took up work as an Alzheimers Society support worker, I learned about ApoE4 and the information has come to sit very heavily with me. Did I inherit the ApoE4 from my mother? Is she going to get Alzheimers very soon? Have I passed it on to my daughter? I have tried to get counselling on the NHS but that is not available for a person in my particular predicament, I was told.

Other examples appear on the ApoE4 Info site, a forum for those whose gene tests show an Alzheimers susceptibility. Have stumbled upon my 4/4 ApoE status. Im still in shock, writes one. Another states: I got paid a $50 Amazon gift-card to take part in a genetic study. I was naive and unprepared.

There is no drug or treatment for Alzheimers and although doctors advise that having a healthy lifestyle will help, the baseline risk for E4 carriers remains high. That is a real problem, said Middleton. Genetic test companies say they offer advice about counselling but that usually turns out to be a YouTube video outlining your risks. Affected people needed one-to-one counselling.

For their part, gene test companies say results about Alzheimers and other such as breast cancer and Parkinsons are often hidden behind electronic locks. A person has to answer several questions to show they really want to open these and is informed of potential risks. But Middleton dismissed these precautions. You know there is medical information about you online and so you will go and find it. It is human nature.

Margaret McCartney, a GP and author of The Patient Paradox, agreed. What worries me is the aggressive way these tests are marketed. People are told all the benefits but there is no mention of the downsides. The NHS is expected to mop these up.

Meanwhile, the gene test company has made its profit and walks away from the mess they have created. I think that is immoral. They should be made to pay for counselling for their customers.

View post:
Warnings over shock dementia revelations from ancestry DNA tests - The Guardian

Read More...

Vet column: Valve disease common cause of canine heart murmurs – Glenwood Springs Post Independent

August 26th, 2017 1:45 pm

Heart disease affects about 10 percent of dogs. Insufficiency of the mitral valve is the most common cause, accounting for 75-80 percent of heart disease cases. Mitral valve disease is more common in small dogs such as the Cavalier King Charles Spaniel, Toy Poodles and Pomeranians.

A degenerative process affecting the mitral valve is thought to be genetic. The first sign of mitral valve disease is a murmur that begins between 6-10 years of age. When the murmur is low grade, there may not be any other signs. However, as the murmur (insufficiency) progresses, signs can include coughing, increased breathing rates or effort, exercise intolerance and even fainting.

The mitral valve is located in the left side of the heart between the left ventricle and left atrium. It provides a vital function by preventing blood from moving backward during heart contraction. Insufficiency means that the valve is not functioning properly allowing blood to leak backward past the valve when the heart contracts.

Understanding how mitral insufficiency affects the body requires further discussion about heart anatomy and function.

The heart is divided into two sides. Each side has two chambers the atrium and the ventricle. The right side of the heart pumps blood to the lungs so that carbon dioxide (CO2) can be released and oxygen (O2) picked up for delivery to the body. Blood with oxygen returning from the lungs to the left side of the heart is pumped to the rest of the body.

When degeneration affects the mitral valve, the edges of the valves become rough and no longer completely close. This allows blood to move backward with each heart contraction. This leaked blood must be pumped again by the heart, resulting in increasing work and inefficiency.

The increased volume of blood in the heart chamber, also results in increased stretching of the heart muscle. This stretching can reduce the efficiency of the heart muscle contractions. When enough blood has leaked backward, it can start backing up into the blood veins leading from the lungs to the heart, causing problems with blood circulation in the lungs.

Mitral insufficiency can be detected by hearing a murmur over the mitral valve. However, it is important to have a full work-up completed to determine how severe the problem is. Tests often include chest X-rays to determine the heart size and changes in lung blood vessels, ECG to determine the presence of abnormal heart rhythms, blood pressure, and liver and kidney test values. Echocardiogram (ultrasound) of the heart provides an assessment of heart structure and function; however, it is not generally needed for mild mitral insufficiency.

Treatment and supportive care depend on the severity of the heart condition. Generally, medications that improve heart contraction, reduce blood pressure and remove excess fluid are used to manage the effects of mitral insufficiency. Reduced sodium diets are considered to be important. Fish oil, vitamins E, C, and B complex, L-carnitine and trace minerals may be of benefit. Herbs such as hawthorn berry (Crataegus oxyacantha) have a wide range of benefits, including safety, improved blood flow to the heart muscle, enhanced strength of the heart contraction,and removal of excess fluid.

When considering supportive care for dogs with mitral insufficiency, it is important to recognize that other parts of the body are indirectly affected. For example, many dogs with heart problems are in a chronic stress mode as the body tries to cope. This ongoing stress can lead to reduced adrenal function. The kidneys can also be affected and may need supportive care.

If you have questions about mitral insufficiency in your dog, contact your veterinarian.

Ron Carsten was one of the first veterinarians in Colorado to use the integrative approach, has lectured widely to veterinarians and has been a pioneer in the therapeutic use of food concentrates to manage clinical problems. In addition to his doctor of veterinary medicine, he holds a Ph.D. in cell and molecular biology and is a Certified Veterinary Acupuncturist and Certified Canine Rehabilitation Therapist. He practices integrative veterinary medicine in Glenwood Springs.

See more here:
Vet column: Valve disease common cause of canine heart murmurs - Glenwood Springs Post Independent

Read More...

Goat experts and other large animal veterinarians – Merced Sun-Star

August 26th, 2017 1:45 pm

Perhaps the title sounds misleading. A large-animal vet develops a veterinary practice caring for the needs of livestock such as cattle (dairy or beef), sheep, goats and pigs. A small animal veterinarian like me is usually slotted into the care of companion pets such as dogs and cats. So when I examine a 200 pound dog, it is still a small animal and likewise there is often confusion about whom to call when the patient is a pot-belly/miniature pig. Not me.

The life of a small animal vet and that of a large animal practitioner are markedly different. One works almost exclusively indoors, dressed neatly, white coat in place. The other weathers life outdoors, facing extremes of blazing heat to icy cold, rain and snow. One always has a sink handy to tidy up. The other uses outdoor hoses more than theyd like. A dairy vet may check over 100 head of cattle in a morning and four farm calls make a full day. A small animal vet may follow the medical strands of more than 25 patients a day, winding through exams, blood results, x-rays and working in a surgery or two. All juggle the demands of unexpected emergency work.

Being in an office most of the day, I rarely interact with my brother and sister large animal veterinarians. So when the pygmy goat from the petting zoo fell over dead I was unhappy, but proceeded to perform a postmortem examination and sent tissue samples off to our regular lab. I had overseen the care of these goats for many years, but they were on the back burner when it came to my interest in the truly exotic Zoo collection. My concerns centered on whether or not the public might have fed something odd to the goat? (Ill jump ahead here: No. The public did not harm the goat). I mulled over the problem but prepared to wait until the pathology report was finished sometime in the next week. And then another goat died.

I was unnerved. The goats were being closely watched and none had shown any outward signs of sickness. They had all lived for more than eight years at the zoo and had never, collectively, suffered a single injury amongst themselves. I immediately sought the expertise of a large-animal veterinarian. The goat expert was on a dairy farm. The return call came in as I was finishing one surgery and about to start another. Gloves still on, I was staring at some x-rays in-between these surgeries when they told me they had Dr. B on the line. Multitasking at its best.

I hurried over, snapping gloves into the waste receptacle and grabbing pen and paper. I introduced myself and launched into a recital of my goat woes. I verified that he had goat experience. I gave him dates, genders, date of deaths, lack of lab results, still pending. I drew breath to spew forth another list of details and heard him gently respond, Yes. I think. I might be able. to help. His measured tones were from a man used to the gentle rhythms of milking machines, contented cows swishing their tails, chewing their cuds. Da-dum da-dum to my staccato dop-dop-dop-dop-dop! I managed to squeeze in a few more hurried sentences (surgery! Waiting!) before he responded calmly, I think I drive past your practice on my way up from this dairy.. I opened my mouth. Closed my mouth. I could hear the clouds, feel the sunshine, almost see the shining black and white hides of the gentle Holsteins he surveyed as we spoke. It was all there in the rhythm of his speech. I told myself to stop yapping before he decided my goat problem would be too stressful for him to bother with.

An hour later Dr. Thomas Bauman drove up in a large truck outfitted for all manner of veterinary ministrations. He spent an hour and a half doing a postmortem on one goat. He had a wicked knife and mulled over the cause of sand in the stomach. He felt it was too much. Did we feed on the ground? No. But little kids feed the zoo goats oat hay pellets and they often dropped to the sand, with all the goats scrambling to get their share. Hmmm. He gave the problem his full attention and we submitted a gazillion samples to the state lab, including an intact eyeball because it would be useful for trace metal analysis. The final answer was a copper deficiency in the feed, to which Pygmy goats are especially susceptible. Hay grown in the San Joaquin Valley is often deficient in copper. The salt lick fed at the zoo did not have added copper because Alpacas are in with the goats and they are susceptible to copper toxicity (too much) if supplemented. So we now feed our goats little capsules of copper wire every six months and all is good.

But sometimes I find myself wishing that I was a large animal veterinarian. Just so I could slow down and smell the ..never mind.

See original here:
Goat experts and other large animal veterinarians - Merced Sun-Star

Read More...

Whole Genome Sequencing Reveals Actual Disease Risk in Healthy Adults – Medical News Bulletin

August 26th, 2017 1:44 pm

Whole genome sequencing, mapping an individuals DNA profile, is a controversial topic. On one hand, the information obtained could change medical practice through creating a new branch of medicine, preventative medicine and individualized health care. Conversely, much of the information is meaningless as the role of the vast majority of genes is unknown. For this reason, the American College of Medical Genetics and Genomics (ACMG) recommend reporting test results for only 59 genes known to be associated with causing disease. Despite this debate, the first two clinical trials evaluating whole genome sequencing in healthy adults were discussed in a recent Science news story.

The first trial was a randomized study involving 100 healthy adults. Participants reported their family medical history to their usual primary-care physician. Whole genome sequencing was performed on 50 randomly selected participants, and five million single nucleotide variants (single base alterations) in 4600 genes were analyzed. The risk of developing polygenic diseases, diseases caused by the combined effects of alterations in multiple genes, was also examined; however, these results were not discussed. In the second unpublished trial, whole exome (protein coding regions) sequencing was performed on 70 healthy adults.

The results of the first trial found at least one alteration associated with disease susceptibility in 11 of the sequenced participants, two of whom manifested clear symptoms. In addition, at least one recessive (single copy) alteration associated with a disease was found in every sequenced individual. Two copies of such alterations are required to cause disease, which has implications for individuals planning a family. Of the 50 sequenced individuals, 34% were referred to a genetic counsellor or had further laboratory tests compared to 16% of non-sequenced participants. Sequenced participants also spent an extra $350 in healthcare costs. Emotional changes, such as anxiety and depression, were not observed in either group six months after the study, and it was noted that many of the participants used the information to make health behavioral changes. Similar results were also found in the second trial: at least one alteration associated with increased risk of disease was detected in 12 (17%) participants.

Although both studies were small and need to be replicated, both suggest that the AMCG reconsider their recommendations regarding the number of disease-associated genes that should be included in routine genetic screening tests. There is no doubt that the information gleaned from this technology will prove valuable to healthcare providers; indeed, some believe that whole genome sequencing should be incorporated into primary care. However, there are fears that this will contribute to escalating medical and insurance costs, which may be justified considering it cost $5000 to obtain one whole-genome sequence in the first trial. There is also a degree of uncertainty surrounding the impact this information has on an individuals psychological, economic and emotional wellbeing. Despite this, the finding that approximately 20% of the population unknowingly carry alterations in disease susceptibility genes certainly adds perspective to the controversy surrounding whole genome sequencing.

Written by Natasha Tetlow, PhD

Cross, R. One in five healthy adults may carry disease-related genetic mutations. Biology Health. 2017. Available at: doi: 10./science.aan7017.

Continue reading here:
Whole Genome Sequencing Reveals Actual Disease Risk in Healthy Adults - Medical News Bulletin

Read More...

Why People May Have Pig Organs Inside Them One Day – TIME

August 26th, 2017 1:44 pm

More than 116,000 Americans are waiting to receive an organ transplant, and about 20 die each day during the wait. Scientists are eager to find solutions to the organ shortage.

That's why a recent landmark report in the journal Science, which detailed the creation of piglets that could potentially provide organs for human transplants in the future, is being heralded as a real game changer. R esearchers from Harvard University, the biotech company eGenesis and other institutions explained how they used cloning and the gene-editing technology CRISPR to create pigs that may be used for human organ transplants down the lineif further research proves them safe and effective.

The findings have obvious implications for the many people waiting for a transplant. But one of the lead study authors, George Church, a geneticist at Harvard and founder of eGenesis, says the promise of pig organs that are compatible with humans may be even bigger. If pig organs could be engineered to be even healthier and more durable than the average human organwhich Church believes is possiblethey could have a profound effect on human health and longevity, he says.

Pig organ research is still in very early stages, and the researchers, including Church, say they are still years away from fully understanding whether pig organ transplants are even safe.

In this study, Church and his colleagues were able to create piglets free of the viruses that would make them unsuitable for human transplant. Church believes that scientists may be able to take it one step further and engineer pig organs to be free of disease and resistant to cancer and some age-related deterioration. One thing about pig organs that I find even more attractive than just helping the transplantation crisis is that it can be preventive medicine, says Church. People who need an organ transplant who are a high risk for hepatitis B, for example, may benefit from a liver engineered to be resistant to the disease. Cells and organs which are resistant to cancers, pathogens and senescence could be better in a preventative sense than the normal human organs which are being replaced, he says.

They may also be fresher, he says. "Many transplant surgeries are canceled with the patient on the operating table because the replacement organ is a few hours too old.

If the use of pigs as organ donors eventually becomes an approved procedure, Church says it could be possible to keep live pigs on site at a hospital. He believes it may also be possible to engineer their organs to be safely preserved though cryopreservationfreezing tissues for storageor other methods, he says, which could cut down on transplant time.

MORE: The New Transplant Revolution

Church says that pig organs could potentially also be engineered to be better matches for recipients, which may reduce the likelihood that the recipients immune system rejects the organ. Heart valves from pigs have already been successfully transplanted into patients. Organ rejection is currently a serious risk, and people who receive an organ transplant must take potent drugs that suppress their immune system to prevent rejection. But the drugs, which are powerful and taken for a person's entire life, also increase their odds of health problems like infections or heart disease.

Even people who do not need a transplant, but want an elective one, may someday benefit from these porcine organs, Church says, though that is a very long way off. The whole idea that we are not going to enhance anyone, I think, is a fake promise, he says. " It would have to start with augmented or enhanced organs needed to deal with patients in very tough life and death conditions in which 'conventional' organs are likely to fail."

Again, the research is still early. But Church says that clinical trials in humans could start in as soon as two years.

Arthur Caplan, a bioethicist at NYU School of Medicine who has studied and written about the ethics of organ transplantation, says he doesnt see a problem with enhanced organs described by Church, instead calling them highly desirable.

It would open the door to use of organs from cancer victims and reduce risk of transmitting viruses, Caplan said in an email response to TIME. I see no downside.

The biggest priority would be to engineer organs that are less likely to be rejected, Caplan adds. The drugs used now to prevent rejection have terrible side effects, but there is no choice. Disease transmission is a real problem, but engineering a 'universal' supply of organs would reduce terrible toll from rejection and cost of drugs.

Before humans are able to use organs from pigs, Caplan says safety studies are required, recipients should be warned about possible risks and experts need to think about who gets priority. It will still likely be several years until physicians are debating these questions, but its clear at least some scientists are considering the possibility.

View post:
Why People May Have Pig Organs Inside Them One Day - TIME

Read More...

Human stem cell defenses activated by irradiation, study finds – Phys.Org

August 26th, 2017 1:41 pm

Credit: MIPT

Researchers from several Russian institutes, including MIPT, have found out how prolonged exposure to ionizing radiation affects human stem cells. They discovered that it causes a cell cycle delay, which leads to faster repairs of radiation-induced DNA double-strand breaks, with fewer errors. It is unclear what the health implications are, in particular, how this affects the risk of developing cancer. The paper was published in Oncotarget.

Ionizing radiation is capable of turning neutral atoms and molecules into charged ions. The human body is inevitably exposed to natural background radiation, with an average person receiving about 3 milligrays of radiation annually. Moreover, one X-ray exam amounts to anywhere from 0.001 to 10 milligrays of additional exposure, depending on the exact procedure. That said, overexposure is dangerousa dose of more than 1,000 milligrays received within a brief period of time causes acute radiation sickness.

To ensure radiation security, it is vital to assess the risks posed by ionizing radiation. Studies of people exposed to radiation have only conclusively established the increased risk of cancer as a result of receiving a high dose of radiation. This led regulating authorities to accept a linear model under which low doses of radiation also increase the risk of cancer. However, experiments show that low-dose radiation exposure either had no adverse biological effect or was even beneficial, as evidenced by prolonged lifespans and less frequent cancer occurrence.

Apart from that, the importance of the so-called dose rate should not be overlooked. Exposure to equal doses of radiation over shorter or longer time intervals has a different effect, with "slow" irradiation causing less harm. The extent to which dose rate affects the biological outcomes is a cause of much debate. In a real-life setting, people are more likely to face prolonged exposure to low-dose radiation, so it is crucial that we understand its effects.

DNA double-strand breaks

One of the negative effects of radiation is the formation of the so-called DNA double-strand breaks, in which both strands of the double helix are severed. Fortunately, the cell is capable of repairing damaged DNA. If one of the two strands is damaged, the other can be used to repair it. However, in the case of a double-strand break, more error-prone mechanisms have to be employed. Left unrepaired or misrepaired, such lesions can give rise to oncological diseases. This explains why research into the effects of radiation on living cells tends to focus on double-strand breaks. Not long ago, it was found that stem cellsfunctionally undifferentiated cellsplay a major part in the formation of tumors by accumulating mutations and passing them on to the specialized cells that are their descendants. However, stem cell response to prolonged irradiation remains poorly understood.

The scientists conducted several experiments using stem cells derived from gingivae, or the gums. They treated the cells with identical radiation doses administered over long and short time spans. The formation of double-strand breaks was monitored using stained H2AX and 53BP1 proteins as markers. With brief but intense radiation exposure, the incidence of both markers was found to increase linearly with the dose. But in the case of prolonged irradiation, the response was linear only up to a certain point, followed by a plateau at 1,000 milligrays. In other words, after reaching a certain number, the lesion count does not continue to rise. A balance of sorts is achieved between break formation and repair.

DNA repair

The cell comes equipped with repair systems capable of mending DNA double-strand breaks. However, following intense irradiation, the cell has to resort to a mechanism known as end joininga quick but faulty procedurein eight out of 10 double-strand breaks. This often leads to chromosomal aberrations. Such misrepairs of DNA breaks can potentially result in cell death, oncogene activation, and anti-oncogene suppression. But there is an alternative mechanism of DNA repair, called homologous recombination. It uses a similar or identical DNA molecule as a template and produces far fewer errors, but it is only available during certain phases in the cell cycle. The researchers monitored homologous recombination using Rad51, another protein marker. During a two-hour long exposure, the amount of Rad51 remained roughly constant, followed by a linear growth afterward. The team hypothesized that prolonged irradiation might activate homologous recombination.

Cell division

Stem cells can be divided into two groups, called proliferating and quiescent, in which the former undergo division, the latter have ceased reproducing, and there is a balance between the two types of cells. The researchers counted the DNA double-strand breaks in proliferating and quiescent cells separately. This is made possible by a certain protein that is only found in cells undergoing division. It turned out that in both types of cells, the number of DNA breaks grew, eventually reaching a constant value.

The researchers also observed that exposure to radiation did not change the roughly four to one ratio between proliferating and quiescent cells. However, a more detailed investigation revealed that four hours of "slow" irradiation results in a considerably increased number of cells in the S and G2 phases of the cyclethat is, DNA synthesis and final preparation for division, respectively. It is during these phases that a copy of the cell's DNA is available for the sake of division, but also to be used as a template in homologous recombination. This fact is a likely explanation for the detection of increased amounts of the Rad51 marker. To put it another way, irradiation causes a delay in the cell cycleas a result, at any given time, there are more cells in those phases that enable homologous recombination. This means it is possible to repair DNA double-strand breaks correctly.

"We have shown that prolonged irradiation of mesenchymal stem cells leads to cell cycle redistribution. This might influence the biological response to radiation," says Sergey Leonov, the director of the Phystech School of Biological and Medical Physics. "Our findings could become the basis of further research into double breaks in stem cells and their effect on tumor formation."

Explore further: How breaks in DNA are repaired

More information: Anastasia Tsvetkova et al, H2AX, 53BP1 and Rad51 protein foci changes in mesenchymal stem cells during prolonged X-ray irradiation, Oncotarget (2017). DOI: 10.18632/oncotarget.19203

Read the rest here:
Human stem cell defenses activated by irradiation, study finds - Phys.Org

Read More...

Bacterial infection stresses hematopoietic stem cells – Medical Xpress

August 26th, 2017 1:41 pm

Bacterial infection activates hematopoietic stem cells in the bone marrow and significantly reduces the ability to produce blood through induced proliferation. Credit: Professor Hitoshi Takizawa

It has been thought that only immune cells would act as the line of defense during bacterial infection. However, recent research has revealed that hematopoietic stem cells, cells that create all other blood cells throughout an individual's lifetime, are also able to respond to the infection. A collaboration between researchers from Japan and Switzerland found that bacterial infection activates hematopoietic stem cells in the bone marrow and significantly reduces their ability to produce blood by forcibly inducing proliferation. These findings indicate that bacterial infections might trigger dysregulation of blood formation, such as that found in anemia or leukemia. This information is important to consider in the development of prevention methods for blood diseases.

Background: Bacterial Infection and the Associated Immune Reaction

When a person becomes infected with a virus or bacteria, immune cells in the blood or lymph react to the infection. Some of these immune cells use "sensors" on their surfaces, called Toll-like receptors (TLR), to distinguish invading pathogens from molecules that are expressed by the host. By doing so, they can attack and ultimately destroy pathogens thereby protecting the body without attacking host cells.

Bone marrow contains hematopoietic stem cells which create blood cells, such as lymphocytes and erythrocytes, throughout life. When infection occurs, a large number of immune cells are activated and consumed. It therefore becomes necessary to replenish these immune cells by increasing blood production in bone marrow. Recent studies have revealed that immune cells are not the only cells that detect the danger signals associated with infection. Hematopoietic stem cells also identify these signals and use them to adjust blood production. However, little was known about how hematopoietic stem cells respond to bacterial infection or how it affected their function.

Proof: Hematopoietic Stem Cell Response to Bacterial Infection

Researchers from Kumamoto University and the University of Zurich analyzed the role of TLRs in hematopoietic stem cells upon bacterial infection, given that both immune cells and hematopoietic stem cells have TLRs. Lipopolysaccharide (LPS), one of the key molecules found in the outer membrane of gram negative bacteria and known to cause sepsis, was given to laboratory animals to generate a bacterial infection model. Furthermore, researchers analyzed the detailed role of TLRs in hematopoietic stem cell regulation by combining genetically modified animals that do not have TLR and related molecules, or agents that inhibit these molecules.

The results showed that LPSs spread throughout the body with some eventually reaching the bone marrow. This stimulated the TLR of the hematopoietic stem cells and induced them to proliferate. They also discovered that while the stimulus promoted proliferation, it also induced stress on the stem cells at the same time. In other words, although hematopoietic stem cells proliferate temporarily upon TLR stimulation, their ability to successfully self-replicate decreases, resulting in diminished blood production. Similar results were obtained after infection with E. coli bacteria.

Future Work

This study reveals that hematopoietic stem cells, while not in charge of immune reactions, are able to respond to bacterial infections resulting in a reduced ability to produce blood. This suggests that cell division of hematopoietic stem cells forced by bacterial infection induces stress and may further cause dysregulated hematopoiesis like that which occurs in anemia or leukemia. "Fortunately we were able to confirm that this molecular reaction can be inhibited by drugs," said one of the study leaders, Professor Hitoshi Takizawa of Kumamoto University's IRCMS. "The medication maintains the production of blood and immune cells without weakening the immune reaction against pathogenic bacteria. It might be possible to simultaneously prevent blood diseases and many bacterial infections in the future."

This finding was posted online in Cell Stem Cell on 21 July 2017, and an illustration from the research content was chosen as the cover of the issue.

Explore further: Innate reaction of hematopoietic stem cells to severe infections

More information: Hitoshi Takizawa et al, Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness, Cell Stem Cell (2017). DOI: 10.1016/j.stem.2017.06.013

Journal reference: Cell Stem Cell

Provided by: Kumamoto University

Go here to read the rest:
Bacterial infection stresses hematopoietic stem cells - Medical Xpress

Read More...

Magnetothermal Genetics: A Fourth Tool in the Brain-Hacking Toolbox – IEEE Spectrum

August 26th, 2017 1:41 pm

A scientist wanting to hack into an animals brain used to have three different tools to choose from: electriccurrent, drugs, and light. Now theres a fourth: magnetic fields. In a paper published last week in the open-access journal eLife, scientists at the University at Buffalo used magneto-thermal genetics to manipulate brain cells in mice, enabling the researchers to control the animals behavior.

Magneto-thermal genetics has been previously shownto activate neurons in anesthetized rodent brains, but this is the first time anyone hasreported using the tool to manipulate animal behavior, says Arnd Pralle, the University at Buffalo biophysicist who led the research.

Brain hacking tools help scientists better understand the wiring of the brainthe arrangement of neural circuits and which onescontrol different movements and behaviors. These tools could someday lead to the development of artificial human eyes and ears, or treatments for paralysis,traumatic brain injury, and diseases such as Parkinsons and depression.

Over the past few years, major funding agencieshave encouraged scientists and bioengineers to focus their work on the bodys internal wiring. The U.S. National Institutes of Health (NIH) and DARPA have been doling out grants for work on both the peripheral and central nervous systems.

Engineers play a key role in the research. The bodys nervous systems communicate, after all, in a language of electrical signals. Researchers must not only map those signals, but also figure out how to interface with them, and override them when they malfunction.

Magnetic fields can do the job (following some complicated, multi-step bioengineering). In Pralles experiments, he and his team injected a virus containing a gene and some helper genetic elementsinto the brains of mice. This genetic material gets incorporated into the DNA of the mouses brain cells, or neurons. The foreign gene makes the neurons heat sensitive. Next, they injected magnetic nanoparticlesinto a specific region of the mouse brain that latch onto the neurons in that region. They then applied alternating magnetic fields, which cause the nanoparticles to heat up a couple of degrees. The rise in temperature triggers the heat-sensitive neurons to open ion channels. Positively-charged ions flow into the neuron, causing it to fire.

Pralle demonstrated proof of the concept in 2010, and others, such as Polina Anikeeva, a professor of materials science and engineering at MIT, have since improved upon it. Those studies confirmed that the technique could indeed activate neurons in the rodent brain.

In the new study, Pralle and his team show how magneto-thermal genetics can manipulate behavior in mice that are awake and freely moving. In their experiments, they activated regions of the brain that made the mice run faster around the perimeter of their cages, spin in circles, and, eerily, freeze the motion of all four paws.

Those same behaviors have been induced in rodents by activating neurons using other brain hacking tools, including optogenetics (in which neurons are genetically sensitized to respond to light), and chemogenetics (in which neurons are genetically sensitized to respond to designer drugs).

Those three toolsmagneto-thermal genetics, optogenetics, and chemogeneticsare new and purely experimental. A fourth toolelectrical stimulationhas been around for decades, with some success in treating Parkinsons, depression, memory loss, paralysis, and epilepsy in humans.

None of the tools has made a dent, relatively speaking, in the range of functions that the brain, spinal cord and peripheral nerves control. Its like owning four different musical instruments and knowing how to play onlya few rudimentary toddler songs on each of them. That untapped potential has inspired scientists to continue to test and develop the tools.

That means overcomingthe shortcomings of each tool. Electrical stimulation of deep brain regions requires, at least for now, an invasive surgical procedure to implant electrodes. That limits the number of patients willing to undergo the surgery. The method is also limited in how specifically it can target small brain regions or cell types.

Optogenetic techniques can target specific neurons, but animals in these experiments usually have to be tethered to an optical fiber or other kind of implant that delivers the light, which can affect their behavior. Study animals undergoing chemogenetic modulation can run free, but their response to the drugs is much slower than to light or electrical stimulation.

Magneto-thermal genetic toolsare non-invasive, tetherless, and induce a response within seconds of turning on the magnetic fields. But theres controversy over how the tool works.

Pralles team has shown that the magnetic nanoparticles injected into the mouse brains latch onto the membranes of the neurons, thus restricting the heating to those membranes rather than diffusing out to the surrounding liquid. This makes little sense from a physics point of view, and contradicts basic principles of heat transfer, saysMarkus Meister, a bioengineer at the California Institute of Technology in Pasadena.

Meister has also argued that previous experiments in magnetogeneticsa sister tool to magneto-thermal geneticsthat involves a different mechanismcontradict the laws of physics.He laid out his back-of-the-envelope calculations last year ina paper ineLife, whichgarnered a lot of attentionin the field of neuromodulation.

However, Pralles main claim, that he successfully used magnetic heating to control animal behavior, looks well supported, Meister says. Bottom line, the reported effects on behavior look real, but just what the mechanism is behind them remains to be understood.

Pralle says his work clearly demonstrates and measures local heating at the cell membrane, showing that it does indeed occur. Why thats happening, however, is unclear, he says.We cannot completely explain why the increase in heat stays within a few tenths or hundredths of nanometers of the neuronal membrane, Pralle says. The heat should diffuse more quickly into the [surrounding] water solution, so it shouldnt have much of a local heating effect.

Several theorists and experimentalists, including Anikeeva, have formulated and are testingmodels to explain the phenomenon. Similar effects have been seen, measured and correctly predicted for laser heating of gold nanoparticles in water, Pralle says.

Anikeeva says she sees nocontroversy in Pralles latest work. Meisters argument is based on a model that isnot applicable to nanoscale heat transport, she says.

Next, Pralle plans to develop, in collaboration with Anikeeva,a magneto-thermal genetics tool that can modulate multiple areas of the brain simultaneously, allowing the researchers to more fully control behavior, or multiple behaviors at one time. If we dream about it we can overcome the technical hurdles, Pralle says.

See more here:
Magnetothermal Genetics: A Fourth Tool in the Brain-Hacking Toolbox - IEEE Spectrum

Read More...

Genetics for everyone – The Boston Globe

August 26th, 2017 1:41 pm

Illustration by cristina span/for the boston globe

The Greeks asked their oracles to predict future fortunes and future losses. The Romans studied the entrails of sacrificed animals for similar reasons. In modern-day medicine, though, soothsayers come in the form of genetic tests.

Ever since the human genome was sequenced almost 15 years ago, tens of thousands of genetic tests have flooded the marketplace. By analyzing someones DNA, often through a blood sample or cheek swab, these tests promise to foretell whether a patient is prone to certain cancers, blessed with the potential to become a star soccer player, or at an elevated risk of having an opioid addiction.

Advertisement

These types of genetic tests are finding an eager audience. The North American genetic testing market, already the largest in the world, was worth $11.9 billion in 2016, by one estimate, and is expected to grow at more than 15 percent a year for the foreseeable future. Companies such as LabCorp, which offer genetic tests via doctor recommendations, and the healthcare giant Roche have moved aggressively into the field. The company 23andMe, a household name because of its ancestry tests, sells health-related tests directly to consumers.

But for a source of medical information to be legally sold in the United States, just how accurate does it need to be?

Like a prediction from a crystal ball, genetic test results are sometimes wrong. Some tests that predict the likelihood a young pregnant woman will have a child with a genetic condition such as Down syndrome may only be correct only 60 percent of the time. Most genetic tests, and many other lab tests, go unvetted by the Food and Drug Administration. That means these tests may not undergo any independent review to make sure they accurately pick up the disease or genetic conditions they claim to be seeking.

Using the worlds first portable DNA lab to sequence beer is a cool thing to do.

The FDA has been wrestling for years with whether and how to do more. During the Obama administration, the agency proposed a new set of draft limits on a whole class of tests, and then put them on hold immediately after Donald Trumps election. This spring, the FDA gave 23andMe permission to market genetic screenings for susceptibility to Alzheimers, Parkinsons, and other conditions. It was the first time the agency blessed direct-to-consumer tests for genetic health risks.

While the debate over genetic testing often follows a pattern familiar from countless other industries business groups want less regulation, and consumer advocates favor more it also raises more cosmic questions: Is a medical test just a piece of information? Or is it something more, if its result leads to dramatic or irreversible action such as chemotherapy or an abortion? And if a data point is factually suspect, or ripe for misinterpretation, when and how should it be offered to consumers?

Advertisement

Especially if regulators stand aside, Americans may soon be swimming in even more tests that vary greatly in their reliability. Yet for some people contemplating a current ailment or their future well-being, getting an answer even an unreliable one may be better than no answer at all.

Especially for people expecting a baby, genetic tests can be hard to resist. I think we all are wanting to know our child doesnt have something... we want them to be healthy, said Mischa Livingstone, a filmmaker and professor who lives in California. Without asking for it, his pregnant wife, Jessica, was given a genetic test that predicted a 99 percent chance their child would have Turner syndrome, a genetic condition that can lead to short stature, heart defects, and other symptoms. But genetic tests for Turner are more often wrong than right a fact the couple didnt know at the time.

They were devastated, and immediately went for more invasive testing, which showed the fetus was fine. But their sense of dread didnt lift until their daughter, now 2 1/2, was born perfectly healthy.

Despite the heartache a faulty genetic test result caused, Livingstone says hed consider asking for one again. I think it feeds into that need for certainty, he said.

Both individuals and society as a whole are intolerant of the unknown, medical sociologists say.

Long before genetic screenings, there was a critical relationship between lab tests and medical treatment. Doctors often wont prescribe drugs or treatment without a positive test result. Insurance payments are rarely processed without diagnostic codes. The rise of genetic testing wont change, and may even amplify, that dynamic.

While some diagnoses may still carry social stigma think schizophrenia, for example they more often may confer legitimacy. Having a gene for alcoholism, for example, can make people view the problem as biological, as opposed to a character flaw. For patients, genetic tests promote a therapeutic optimism a hope that they can be treated and cured for an immediate problem or a future one, according to Michael Bury, professor emeritus at Royal Holloway, University of London, who studies society and illness.

A test alone can feel like a step forward. Undergoing a screening, said Natalie Armstrong, professor of healthcare improvement research at the University of Leicester, can make people feel that at least they are doing something proactive.

Interestingly, one study indicated that certain direct-to-consumer genetic tests dont affect users behavior or anxiety levels, bolstering the argument that people may use the information as data points, not a surefire prediction of their own fate.

Many bioethicists are unpersuaded. On an individual basis, it is tempting to discount the pitfalls of a little extra information, says Beth Peshkin, an oncology professor and genetic counselor at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. But on a population level the implications of inaccurate results can be costly and, sometimes, deadly.

One of the most cited examples of this harm is from a 2008 genetic test for ovarian cancer that misdiagnosed women, some of whom had their ovaries removed unnecessarily before the test was pulled from the market. Because test makers do not have to report when a test turns out to be wrong in fact many people may never know when a test result is a false positive or negative FDA officials have said it has been almost impossible to assess the overall harm from all unregulated tests.

Cost is another concern that may arise from the overuse of genetic tests that proliferate without meaningful oversight. Tests often beget more tests that cost an ever-escalating amount of money. Enough testing, will invariably pick up something abnormal in a patient, even though it may not harm them, some experts believe.

In some ways its easy for us to try and find something definitive and act on that even though it has nothing to do with what is wrong with the patient, said H. Gilbert Welch, a cancer research at Dartmouth College who has written extensively on the dangers of overtesting. Genetics is an amazing tool... but to what extent does that data predict something that you care about? Is it useful knowledge?

Get This Week in Opinion in your inbox:

Globe Opinion's must-reads, delivered to you every Sunday.

The American Clinical Laboratory Association, the key trade group for genetic test makers, and other advocates of lighter regulation argue that bad tests are rare, and that its more important for the free market to allow innovation. With more tests in place to identify disease, cures come next, they say.

So far, the public has shown little concern about the fallout of genetic testing. While a 2016 poll showed only 6 percent of American adults have undergone genetic testing, 56 percent of them said they would want to if it could predict cancer or a disease like Alzheimers. Most Americans, the poll found, believe genetic tests for predicting disease are mostly accurate and reliable.

Safety advocates best chance to tighten regulation may have already passed. The world of genetic testing becomes more free-wheeling and consumer-driven all the time. By one industry estimate, 10 new genetic testing products enter the market each day. Despite considerable skepticism from medical experts, new apps purport to use data from gene sequencing to develop personalized diet plans and fitness routines.

The FDAs now-shelved rules would have classified genetic and other tests according to how much harm they could cause if their result was wrong. For example, a new genetic test for colon cancer, which requires intrusive and costly treatment, likely would have been subject to full FDA review; the maker of a test that predicts mere baldness might only have had to register it with the agency and report any known problems with it. Under the Trump administration, the agency appears less likely to draw such distinctions or impose new restrictions at all.

People want answers soon, and their inclination is to believe what appears to be solid, unassailable medicine, said Robert Klitzman, a Columbia University bioethicist. Individuals will need to evaluate these tests carefully. The notion of being able to tell your fortune has great lure. But its a little bit of hubris. We still dont know so much.

Genetic testing, still in its infancy, promises a measure of clarity about the future of our bodies. But as genetic science rapidly evolves, that modern-day crystal ball raises vexing new questions and creates its own kind of uncertainty.

Read the original:
Genetics for everyone - The Boston Globe

Read More...

YHS Teacher Attends Genetics Workshop – Yankton Daily Press

August 26th, 2017 1:41 pm

Sanford Health and Harvard Medical School have collaborated to bring information and education about personal genetics and research to classrooms and communities in Massachusetts and South Dakota.

One such program the two facilities have created is the Personal Genetics Education Project (pgEd), which offers workshops that bring awareness and create community understanding about development in genetics and how they affect health.

Lindsay Kortan, who teaches ninth-grade physical science at Yankton High School (YHS), jumped at the chance to learn more about genetics by attending the pgEd Genetics and Social Justice Summer Institute in Brockton, Massachusetts this summer.

A member of the South Dakota Science Teachers Association, Kortan is also a Sanford ambassador and has done research with the organization for several years. It was through this involvement that she was invited to attend the weeklong pgEd conference.

"The setup was them showing (the attendees) their lesson plans, allowing us to experience what type of content is in the lesson and what kind of discussions/questions we might have in the classroom," she explained. "It covered a wide range of things, everything from the eugenics movement to ethics in genetics testing to personal genetics testing."

As someone who developed a strong interest in genetics through her studies at the University of South Dakota, all of this was right up Kortans alley.

"(Genetics) was one of my favorite topics to teach in a biology classroom," she said.

Prior to coming to YHS, Kortan had taught grades 10-12 science biology, physiology, physics and chemistry in the Bon Homme school district for five years.

She admitted that introducing what she learned at the conference into her current class will be difficult, but plans to spread her newfound information in other ways.

"Ive shared my knowledge with some of the other teachers and offered to help them incorporate it into their classrooms if theyre interested," she said.

She plans to be part of next summers workshop in Sioux Falls, which will be hosted by Sanford PROMISE and pgEd.

"From an education perspective, the pgED information is great for teaching our kids those critical-thinking and difficult life-decision questions they might have to encounter in their lifetime, especially now with the way genetic testing and technology is advancing," she said. "Its getting more prevalent in making decisions, even down to doctors looking at your genetic code to know what drugs they should prescribe to you, or whether the drug will be effective or not. Its important for kids to know that information before they get into those critical situations where they have to make an (important) decision. The process of going through that critical thinking and seeing different viewpoints is always a good thing in the classroom.

"Im currently pregnant, so some of those genetic questions that you get asked because of pregnancy and fertility treatments (that) I received really brought it to a personal level for me."

Follow @ReillyBiel on Twitter.

See more here:
YHS Teacher Attends Genetics Workshop - Yankton Daily Press

Read More...

Hendrix Genetics expand layer distribution in the US – Poultry World (subscription)

August 26th, 2017 1:41 pm

Eggs

News Aug 25, 2017481views

Hendrix Genetics has officially opened a new $18.5m hatchery in Nebraska, creating 45 jobs, as it aims to expand its share of the market.

The new layer hatchery has a capacity to produce 24m female chicks per year.

Key contract growers located near the new hatchery will rear and house the birds during production. The company is already working with 8 contract growers in the Grand Island area who have invested in new barns with a capacity of 40,000 birds per barn.

The Grand Island contract growers will complete the new national production hub for Hendrix Genetics in the US, enabling the firm to meet another 10% of the total US layer market needs.

Ron Joerissen, Hendrix Genetics production director layers, said: The new hatchery signifies a major step in supplying the US layer market with top quality laying hens. We are dedicated to breed for the egg producing industry of today and tomorrow.

Nebraskas Governor Pete Ricketts described the plant as a great example of value-added agriculture.

It is not only a $20m investment here that will create between 40 to 50 jobs but it is going to allow area farmers to put up these barns for the eggs that will supply this hatchery and a diversified revenue stream for those farmers who are participating, he said.

To comment, login here Or register to be able to comment.

Continued here:
Hendrix Genetics expand layer distribution in the US - Poultry World (subscription)

Read More...

Page 950«..1020..949950951952..960970..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick